LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market ...

The monsoon season brings not just cool relief but also a sharp rise in eye infections like conjunctivitis, styes, and ...

A novel eye drop formulation shows antioxidant effects and may protect corneal epithelial cells, according to research presented at AOA 2025.

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Dry eye can show up in many different ways. Aside from constant burning, itching and discomfort, dry eye can feel like a gritty or scratchy sensation, or a tired or heavy feeling. It can also cause ...

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

Itchy eyes can be uncomfortable, even crazy-making, and many of us experience them at one time or another. If you’re ...

Lifitegrast 5.0%, a topical anti-inflammatory therapy, effectively reduces signs and biomarkers of dry eye disease in 12 ...

I would have had no clue what a "bleph" was. Now, it's something that my friends and I regularly reference wanting, (half) jokingly, in casual conversation. In case you're not quite as vain as we are: ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...

ST-100 is a novel collagen mimetic peptide designed to repair damaged collagen in the eye and restore homeostatic cell signaling in the ocular epithelium.

Stuart Therapeutics’ dry eye disease drug has failed to demonstrate that it can increase tear production in a phase 3 test.